
Tauramox™ (moxidectin) Injectable Solution is the first generic Cydectin® (moxidectin) Injectable for the treatment of infections and infestations due to internal and external parasites in beef and non-lactating dairy cattle.
The global Moxidectin Injection market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Moxidectin Injection Industry Forecast” looks at past sales and reviews total world Moxidectin Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Moxidectin Injection sales for 2024 through 2030. With Moxidectin Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Moxidectin Injection industry.
This Insight Report provides a comprehensive analysis of the global Moxidectin Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Moxidectin Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Moxidectin Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Moxidectin Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Moxidectin Injection.
United States market for Moxidectin Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Moxidectin Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Moxidectin Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Moxidectin Injection players cover Norbrook, Hebei Hope Harmony Pharmaceutical, 4Farmers, Almer Feed & Supply Inc. and Jinan Qinmu Fine Chemical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Moxidectin Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
0.1
0.01
0.005
Segmentation by application
Cattle
Sheep
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Norbrook
Hebei Hope Harmony Pharmaceutical
4Farmers
Almer Feed & Supply Inc.
Jinan Qinmu Fine Chemical
Elanco US Inc.
Manus Aktteva
Key Questions Addressed in this Report
What is the 10-year outlook for the global Moxidectin Injection market?
What factors are driving Moxidectin Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Moxidectin Injection market opportunities vary by end market size?
How does Moxidectin Injection break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Moxidectin Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Moxidectin Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Moxidectin Injection by Country/Region, 2019, 2023 & 2030
2.2 Moxidectin Injection Segment by Type
2.2.1 0.1
2.2.2 0.01
2.2.3 0.005
2.3 Moxidectin Injection Sales by Type
2.3.1 Global Moxidectin Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Moxidectin Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Moxidectin Injection Sale Price by Type (2019-2024)
2.4 Moxidectin Injection Segment by Application
2.4.1 Cattle
2.4.2 Sheep
2.4.3 Other
2.5 Moxidectin Injection Sales by Application
2.5.1 Global Moxidectin Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Moxidectin Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Moxidectin Injection Sale Price by Application (2019-2024)
3 Global Moxidectin Injection by Company
3.1 Global Moxidectin Injection Breakdown Data by Company
3.1.1 Global Moxidectin Injection Annual Sales by Company (2019-2024)
3.1.2 Global Moxidectin Injection Sales Market Share by Company (2019-2024)
3.2 Global Moxidectin Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Moxidectin Injection Revenue by Company (2019-2024)
3.2.2 Global Moxidectin Injection Revenue Market Share by Company (2019-2024)
3.3 Global Moxidectin Injection Sale Price by Company
3.4 Key Manufacturers Moxidectin Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Moxidectin Injection Product Location Distribution
3.4.2 Players Moxidectin Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Moxidectin Injection by Geographic Region
4.1 World Historic Moxidectin Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Moxidectin Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Moxidectin Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Moxidectin Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Moxidectin Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Moxidectin Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Moxidectin Injection Sales Growth
4.4 APAC Moxidectin Injection Sales Growth
4.5 Europe Moxidectin Injection Sales Growth
4.6 Middle East & Africa Moxidectin Injection Sales Growth
5 Americas
5.1 Americas Moxidectin Injection Sales by Country
5.1.1 Americas Moxidectin Injection Sales by Country (2019-2024)
5.1.2 Americas Moxidectin Injection Revenue by Country (2019-2024)
5.2 Americas Moxidectin Injection Sales by Type
5.3 Americas Moxidectin Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Moxidectin Injection Sales by Region
6.1.1 APAC Moxidectin Injection Sales by Region (2019-2024)
6.1.2 APAC Moxidectin Injection Revenue by Region (2019-2024)
6.2 APAC Moxidectin Injection Sales by Type
6.3 APAC Moxidectin Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Moxidectin Injection by Country
7.1.1 Europe Moxidectin Injection Sales by Country (2019-2024)
7.1.2 Europe Moxidectin Injection Revenue by Country (2019-2024)
7.2 Europe Moxidectin Injection Sales by Type
7.3 Europe Moxidectin Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Moxidectin Injection by Country
8.1.1 Middle East & Africa Moxidectin Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Moxidectin Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Moxidectin Injection Sales by Type
8.3 Middle East & Africa Moxidectin Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Moxidectin Injection
10.3 Manufacturing Process Analysis of Moxidectin Injection
10.4 Industry Chain Structure of Moxidectin Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Moxidectin Injection Distributors
11.3 Moxidectin Injection Customer
12 World Forecast Review for Moxidectin Injection by Geographic Region
12.1 Global Moxidectin Injection Market Size Forecast by Region
12.1.1 Global Moxidectin Injection Forecast by Region (2025-2030)
12.1.2 Global Moxidectin Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Moxidectin Injection Forecast by Type
12.7 Global Moxidectin Injection Forecast by Application
13 Key Players Analysis
13.1 Norbrook
13.1.1 Norbrook Company Information
13.1.2 Norbrook Moxidectin Injection Product Portfolios and Specifications
13.1.3 Norbrook Moxidectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Norbrook Main Business Overview
13.1.5 Norbrook Latest Developments
13.2 Hebei Hope Harmony Pharmaceutical
13.2.1 Hebei Hope Harmony Pharmaceutical Company Information
13.2.2 Hebei Hope Harmony Pharmaceutical Moxidectin Injection Product Portfolios and Specifications
13.2.3 Hebei Hope Harmony Pharmaceutical Moxidectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Hebei Hope Harmony Pharmaceutical Main Business Overview
13.2.5 Hebei Hope Harmony Pharmaceutical Latest Developments
13.3 4Farmers
13.3.1 4Farmers Company Information
13.3.2 4Farmers Moxidectin Injection Product Portfolios and Specifications
13.3.3 4Farmers Moxidectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 4Farmers Main Business Overview
13.3.5 4Farmers Latest Developments
13.4 Almer Feed & Supply Inc.
13.4.1 Almer Feed & Supply Inc. Company Information
13.4.2 Almer Feed & Supply Inc. Moxidectin Injection Product Portfolios and Specifications
13.4.3 Almer Feed & Supply Inc. Moxidectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Almer Feed & Supply Inc. Main Business Overview
13.4.5 Almer Feed & Supply Inc. Latest Developments
13.5 Jinan Qinmu Fine Chemical
13.5.1 Jinan Qinmu Fine Chemical Company Information
13.5.2 Jinan Qinmu Fine Chemical Moxidectin Injection Product Portfolios and Specifications
13.5.3 Jinan Qinmu Fine Chemical Moxidectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Jinan Qinmu Fine Chemical Main Business Overview
13.5.5 Jinan Qinmu Fine Chemical Latest Developments
13.6 Elanco US Inc.
13.6.1 Elanco US Inc. Company Information
13.6.2 Elanco US Inc. Moxidectin Injection Product Portfolios and Specifications
13.6.3 Elanco US Inc. Moxidectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Elanco US Inc. Main Business Overview
13.6.5 Elanco US Inc. Latest Developments
13.7 Manus Aktteva
13.7.1 Manus Aktteva Company Information
13.7.2 Manus Aktteva Moxidectin Injection Product Portfolios and Specifications
13.7.3 Manus Aktteva Moxidectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Manus Aktteva Main Business Overview
13.7.5 Manus Aktteva Latest Developments
14 Research Findings and Conclusion
*If Applicable.
